NABL vs UTHR · P/E 103, rev $270.6M vs P/E 20, rev $1.56B
N-Able Inc (NABL) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
N-Able Inc (NABL) is a information technology services company listed on US.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported NABL revenue for 2026-06-30 was $270.6M. Net income was $77.0K. NABL currently screens at market cap $1.56B and trailing P/E 103.1.
Latest reported UTHR revenue for 2026-06-30 was $1.56B. Net income was $607.9M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
NABL currently screens at market cap $1.56B and trailing P/E 103.1. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the NABL and UTHR stock pages for the full models.
Not investment advice.